During the past decade, Krakowska Akademia Neurologii Sp. z o.o. conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Krakowska Akademia Neurologii Sp. z o.o." are "Agitation" (1 trials), "Alzheimer's Type Dementia" (1 trials) and "Parkinson's Disease" (1 trials). Many other conditions were trialed in "Krakowska Akademia Neurologii Sp. z o.o." in a lesser frequency.

Most popular intervention types in "Krakowska Akademia Neurologii Sp. z o.o." are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "IPX066 145 mg" (1 trials), "IPX066 195 mg" (1 trials), "IPX066 245 mg" (1 trials), "IPX066 95 mg" (1 trials) and "Masupirdine 100 mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Krakowska Akademia Neurologii Sp. z o.o." are 2 trials for "All" genders.

Currently, there are NaN active trials in "Krakowska Akademia Neurologii Sp. z o.o.". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Krakowska Akademia Neurologii Sp. z o.o., undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Krakowska Akademia Neurologii Sp. z o.o., 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".